ABSTRACT
Background
This study aimed to evaluate the effectiveness of tocilizumab in mechanically ventilated patients with coronavirus disease 2019 (COVID-19).
Research design and methods
This retrospective multicenter study included adults (≥18 years) diagnosed with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by real-time polymerase chain reaction (RT-PCR) from nasopharyngeal swab, and requiring invasive mechanical ventilation during admission. Survival analyses with inverse propensity score treatment weighting (IPTW) and propensity score matching (PSM) were conducted. To account for immortal bias, we used Cox proportional modeling with time-dependent covariance. Competing risk analysis was performed for the extubation endpoint.
Results
A total of 556 (tocilizumab = 193, control = 363) patients were included. Males constituted the majority of the participants (69.2% in tocilizumab arm,74.1% in control arm). Tocilizumab was not associated with a reduction in mortality with hazard ratio [(HR) = 0.82,95% confidence interval (95%CI): 0.62–1.10] in the Inverse propensity score weighting (IPTW) analysis and (HR = 0.86,95% CI: 0.64–1.16) in the PSM analysis. However, tocilizumab was associated with an increased rate of extubation (33.6%) compared to the control arm (11.9%); subdistributional hazards (SHR) = 3.1, 95% CI: 1.86–5.16).
Conclusions
Although tocilizumab was not found to be effective in reducing mortality, extubation rate while on mechanical ventilation was higher among tocilizumab treated group.
KEYWORDS (MeSH):
Acknowledgements
The authors would like to thank the staff at Ministry of Health hospitals. This publication was supported by the Deanship of Scientific Research at Prince Sattam bin Abdulaziz University, King Faisal Specialist Hospital and Research Center and Deanship of Scientific Research at King Faisal University.
Declaration of interest
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
Reviewer disclosures
Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.
Authors Contributions
Conceptualization was by Y.A.M; A.A (Ahmad Alamer); A.A.A (Ahmed A Alrashed); A.S.A. Statistics, methodology, software and interpretation of the results was done by A.A (Ahmad Alamer). Consultation on statistics was provided by I.A. The first draft of the paper was done by A.A, Y.A.M., and D.A. Abstract was drafted by N.A and.. All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, declare their responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.
Supplementary material
Supplemental data for this article can be accessed here
Correction Statement
This article has been republished with minor changes. These changes do not impact the academic content of the article.